URNG.L vs. GNOG.L

Last updated Jun 5, 2026

URNG.L (Global X Uranium UCITS ETF USD Accumulating) and GNOG.L (Global X Genomics & Biotechnology UCITS ETF) are both exchange-traded funds - URNG.L is a Commodity Producers Equities fund tracking the Solactive Global Uranium & Nuclear Components, while GNOG.L is a Health & Biotech Equities fund tracking the MSCI World/Health Care NR USD. Both are passively managed. Over the past 3 years, URNG.L returned 36.12%/yr vs -1.86%/yr for GNOG.L. At a 0.35 correlation, their price movements are largely independent. URNG.L charges 0.65%/yr vs 0.50%/yr for GNOG.L.

Performance

URNG.L vs. GNOG.L - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in Global X Uranium UCITS ETF USD Accumulating (URNG.L) and Global X Genomics & Biotechnology UCITS ETF (GNOG.L). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, URNG.L achieves a 18.27% return, which is significantly higher than GNOG.L's 12.27% return.

URNG.L

• 1D: -0.48%
• 1M: -7.77%
• YTD: 18.27%
• 6M: 7.25%
• 1Y: 64.64%
• 3Y*: 36.12%
• 5Y*: —
• 10Y*: —

GNOG.L

• 1D: 5.70%
• 1M: 13.66%
• YTD: 12.27%
• 6M: 9.47%
• 1Y: 59.40%
• 3Y*: -1.86%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

URNG.L vs. GNOG.L - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
URNG.L Global X Uranium UCITS ETF USD Accumulating	18.27%	58.50%	2.96%	30.86%	-14.11%
GNOG.L Global X Genomics & Biotechnology UCITS ETF	12.27%	12.03%	-16.98%	-11.35%	-0.47%

Correlation

The correlation between URNG.L and GNOG.L is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.31
Correlation (3Y) Calculated over the trailing 3-year period	0.29
Correlation (All Time) Calculated using the full available price history since Apr 25, 2022	0.35

Return for Risk

URNG.L vs. GNOG.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

URNG.L

URNG.L Risk / Return Rank: 37
URNG.L Sharpe Ratio Rank: 37
URNG.L Sortino Ratio Rank: 38
URNG.L Omega Ratio Rank: 36
URNG.L Calmar Ratio Rank: 40
URNG.L Martin Ratio Rank: 34

GNOG.L

GNOG.L Risk / Return Rank: 62
GNOG.L Sharpe Ratio Rank: 66
GNOG.L Sortino Ratio Rank: 65
GNOG.L Omega Ratio Rank: 58
GNOG.L Calmar Ratio Rank: 70
GNOG.L Martin Ratio Rank: 52

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

URNG.L vs. GNOG.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Global X Uranium UCITS ETF USD Accumulating (URNG.L) and Global X Genomics & Biotechnology UCITS ETF (GNOG.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	URNG.L	GNOG.L	Difference
Sharpe ratio: Return per unit of total volatility	1.31	2.16	-0.85
Sortino ratio: Return per unit of downside risk	1.93	2.95	-1.02
Omega ratio: Gain probability vs. loss probability	1.23	1.35	-0.12
Calmar ratio: Return relative to maximum drawdown	1.97	3.44	-1.47
Martin ratio: Return relative to average drawdown	5.06	8.72	-3.66
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

URNG.L vs. GNOG.L - Sharpe Ratio Comparison

The current URNG.L Sharpe Ratio is 1.31, which is lower than the GNOG.L Sharpe Ratio of 2.16. The chart below compares the historical Sharpe Ratios of URNG.L and GNOG.L, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	URNG.L	GNOG.L	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.31	2.16	-0.85
Sharpe Ratio (All Time) Calculated using the full available price history	0.52	-0.36	+0.88

Drawdowns

URNG.L vs. GNOG.L - Drawdown Comparison

The maximum URNG.L drawdown since its inception was -38.98%, smaller than the maximum GNOG.L drawdown of -67.50%. Use the drawdown chart below to compare losses from any high point for URNG.L and GNOG.L.

Drawdown Indicators

	URNG.L	GNOG.L	Difference
Max Drawdown Largest peak-to-trough decline	-38.98%	-67.50%	+28.52%
Max Drawdown (1Y) Largest decline over 1 year	-32.59%	-17.16%	-15.43%
Max Drawdown (3Y) Largest decline over 3 years	-38.98%	-47.97%	+8.99%
Current Drawdown Current decline from peak	-13.93%	-41.78%	+27.85%
Average Drawdown Average peak-to-trough decline	-12.79%	-44.20%	+31.41%
Ulcer Index Depth and duration of drawdowns from previous peaks	12.75%	6.79%	+5.96%

Volatility

URNG.L vs. GNOG.L - Volatility Comparison

Global X Uranium UCITS ETF USD Accumulating (URNG.L) has a higher volatility of 14.89% compared to Global X Genomics & Biotechnology UCITS ETF (GNOG.L) at 7.97%. This indicates that URNG.L's price experiences larger fluctuations and is considered to be riskier than GNOG.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	URNG.L	GNOG.L	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.89%	7.97%	+6.92%
Volatility (6M) Calculated over the trailing 6-month period	33.87%	19.73%	+14.14%
Volatility (1Y) Calculated over the trailing 1-year period	49.10%	27.38%	+21.72%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	39.66%	31.21%	+8.45%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	39.66%	31.21%	+8.45%

URNG.L vs. GNOG.L - Expense Ratio Comparison

URNG.L has a 0.65% expense ratio, which is higher than GNOG.L's 0.50% expense ratio.

Dividends

URNG.L vs. GNOG.L - Dividend Comparison

Neither URNG.L nor GNOG.L has paid dividends to shareholders.

Tickers have no history of dividend payments

Frequently Asked Questions

Can I hold both URNG.L and GNOG.L in my portfolio?

URNG.L and GNOG.L have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, URNG.L or GNOG.L?

On fees, GNOG.L is cheaper at 0.50% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, URNG.L or GNOG.L?

GNOG.L is cheaper with a 0.50% expense ratio, compared with 0.65% for URNG.L.

What is the main difference between URNG.L and GNOG.L?

URNG.L is categorized as Commodity Producers Equities, while GNOG.L is Health & Biotech Equities. URNG.L tracks Solactive Global Uranium & Nuclear Components, while GNOG.L tracks MSCI World/Health Care NR USD. Their fees differ too: 0.65% for URNG.L and 0.50% for GNOG.L.